Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis

NCT07871604 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07871604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07871604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 10, 2026
Completion date
September 21, 2029
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis cardiovascular disease